Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results